These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16934696)

  • 1. A novel 125I-labeled daunorubicin derivative for radionuclide-based cancer therapy.
    Ickenstein LM; Edwards K; Sjöberg S; Carlsson J; Gedda L
    Nucl Med Biol; 2006 Aug; 33(6):773-83. PubMed ID: 16934696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluation and biodistribution of HER2-targeted liposomes loaded with an (125)I-labelled DNA-intercalator.
    Fondell A; Edwards K; Unga J; Kullberg E; Park JW; Gedda L
    J Drug Target; 2011 Nov; 19(9):846-55. PubMed ID: 21692679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diethylstilbestrol (DES) labeled with Auger emitters: potential radiopharmaceutical for therapy of estrogen receptor-positive tumors and their metastases?
    Fischer T; Schomacker K; Schicha H
    Int J Radiat Biol; 2008 Dec; 84(12):1112-22. PubMed ID: 19061136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclisome: a novel concept for radionuclide therapy using targeting liposomes.
    Fondell A; Edwards K; Ickenstein LM; Sjöberg S; Carlsson J; Gedda L
    Eur J Nucl Med Mol Imaging; 2010 Jan; 37(1):114-23. PubMed ID: 19662408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotoxicity of iodine-125-labeled oligodeoxyribonucleotides in mammalian cells.
    Sedelnikova OA; Panyutin IG; Thierry AR; Neumann RD
    J Nucl Med; 1998 Aug; 39(8):1412-8. PubMed ID: 9708519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and radioiodination of some daunorubicin and doxorubicin derivatives.
    Ghirmai S; Mume E; Tolmachev V; Sjöberg S
    Carbohydr Res; 2005 Jan; 340(1):15-24. PubMed ID: 15620662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 125I-labeled quercetin as a novel DNA-targeted radiotracer.
    Hosseinimehr SJ; Tolmachev V; Stenerlöw B
    Cancer Biother Radiopharm; 2011 Aug; 26(4):469-75. PubMed ID: 21797673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syntheses and biological activities of daunorubicin analogs with uncommon sugars.
    Zhu L; Cao X; Chen W; Zhang G; Sun D; Wang PG
    Bioorg Med Chem; 2005 Dec; 13(23):6381-7. PubMed ID: 16055335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MGN-3/Biobran, modified arabinoxylan from rice bran, sensitizes human breast cancer cells to chemotherapeutic agent, daunorubicin.
    Gollapudi S; Ghoneum M
    Cancer Detect Prev; 2008; 32(1):1-6. PubMed ID: 18406070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 123I-ITdU-mediated nanoirradiation of DNA efficiently induces cell kill in HL60 leukemia cells and in doxorubicin-, beta-, or gamma-radiation-resistant cell lines.
    Reske SN; Deisenhofer S; Glatting G; Zlatopolskiy BD; Morgenroth A; Vogg AT; Buck AK; Friesen C
    J Nucl Med; 2007 Jun; 48(6):1000-7. PubMed ID: 17504875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct assessment of drug penetration into tissue using a novel application of three-dimensional cell culture.
    Kyle AH; Huxham LA; Chiam AS; Sim DH; Minchinton AI
    Cancer Res; 2004 Sep; 64(17):6304-9. PubMed ID: 15342419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 4'-epi-iodo-4'-deoxy-daunorubicin, a potential cancer radiotherapeutic agent.
    Murali D; DeJesus OT
    Bioorg Med Chem Lett; 1998 Dec; 8(23):3419-22. PubMed ID: 9873745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daunorubicin and doxorubicin inhibit the [(11)C]choline accumulation in cancer cells.
    Mikecz P; Márián T; Miklovicz T; Galuska L; Krasznai Z; Tóth A; Goda K; Trón L; Hernádi Z; Krasznai ZT
    Appl Radiat Isot; 2009 Oct; 67(10):1806-11. PubMed ID: 19674913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential tumor targeting and selective tumor cell cytotoxicity of 5-[131/125I]iodo-4'-thio-2'-deoxyuridine.
    Morgenroth A; Deisenhofer S; Glatting G; Kunkel FH; Dinger C; Zlatopolskiy B; Vogg AT; Kull T; Reske SN
    Clin Cancer Res; 2008 Nov; 14(22):7311-9. PubMed ID: 19010846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an oxime bond containing daunorubicin-gonadotropin-releasing hormone-III conjugate as a potential anticancer drug.
    Szabó I; Manea M; Orbán E; Csámpai A; Bosze S; Szabó R; Tejeda M; Gaál D; Kapuvári B; Przybylski M; Hudecz F; Mezo G
    Bioconjug Chem; 2009 Apr; 20(4):656-65. PubMed ID: 19296605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auger radiation-induced, antisense-mediated cytotoxicity of tumor cells using a 3-component streptavidin-delivery nanoparticle with 111In.
    Liu X; Wang Y; Nakamura K; Kawauchi S; Akalin A; Cheng D; Chen L; Rusckowski M; Hnatowich DJ
    J Nucl Med; 2009 Apr; 50(4):582-90. PubMed ID: 19289423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derlin-1 is overexpressed on the tumor cell surface and enables antibody-mediated tumor targeting therapy.
    Ran Y; Hu H; Hu D; Zhou Z; Sun Y; Yu L; Sun L; Pan J; Liu J; Liu T; Yang Z
    Clin Cancer Res; 2008 Oct; 14(20):6538-45. PubMed ID: 18927294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel daunorubicin-carrier peptide conjugates derived from human calcitonin segments.
    Krauss U; Kratz F; Beck-Sickinger AG
    J Mol Recognit; 2003; 16(5):280-7. PubMed ID: 14523941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular therapy of human neuroblastoma cells using Auger electrons of 111In-labeled N-myc antisense oligonucleotides.
    Watanabe N; Sawai H; Ogihara-Umeda I; Tanada S; Kim EE; Yonekura Y; Sasaki Y
    J Nucl Med; 2006 Oct; 47(10):1670-7. PubMed ID: 17015904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel action of epidermal growth factor on caspase 3 and its potential as a chemotherapeutic adjunct for neuroblastoma.
    Chiu B; Mirkin B; Madonna MB
    J Pediatr Surg; 2007 Aug; 42(8):1389-95. PubMed ID: 17706502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.